187 related articles for article (PubMed ID: 34303335)
1. Nanosponge Approach -A Plethora of Opportunities as a Promising Nanocarrier for Novel Drug Delivery.
Bhavin SE; Anuradha G
Recent Pat Nanotechnol; 2022; 16(4):271-282. PubMed ID: 34303335
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin based nanosponges for pharmaceutical use: a review.
Tejashri G; Amrita B; Darshana J
Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
[TBL] [Abstract][Full Text] [Related]
3. Nanosponges- Versatile Platform as Drug Carrier.
Kandekar U; Pujari R; Munot N; Chorge T; Lone K; Kamble P; Kishanchand K
Recent Pat Nanotechnol; 2023; 17(2):91-103. PubMed ID: 36748244
[TBL] [Abstract][Full Text] [Related]
4. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
5. Nanosponges -A Promising Novel Drug Delivery System.
Pandey P; Purohit D; Dureja H
Recent Pat Nanotechnol; 2018; 12(3):180-191. PubMed ID: 30251614
[TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Patent Review on β-cyclodextrin Cross-linked Nanosponges for Multiple Applications.
Pawar S; Shende P
Recent Pat Nanotechnol; 2020; 14(1):75-89. PubMed ID: 31161998
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin-based nanosponges as promising carriers for active pharmaceutical ingredient.
Jawaharlal S; Subramanian S; Palanivel V; Devarajan G; Veerasamy V
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23597. PubMed ID: 38037252
[TBL] [Abstract][Full Text] [Related]
8. The ascension of nanosponges as a drug delivery carrier: preparation, characterization, and applications.
Tiwari K; Bhattacharya S
J Mater Sci Mater Med; 2022 Mar; 33(3):28. PubMed ID: 35244808
[TBL] [Abstract][Full Text] [Related]
9. The application of nanosponges to cancer drug delivery.
Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R
Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge.
Dhakar NK; Caldera F; Bessone F; Cecone C; Pedrazzo AR; Cavalli R; Dianzani C; Trotta F
Carbohydr Polym; 2019 Nov; 224():115168. PubMed ID: 31472867
[TBL] [Abstract][Full Text] [Related]
11. Drug-Encapsulated Cyclodextrin Nanosponges.
Tannous M; Caldera F; Hoti G; Dianzani U; Cavalli R; Trotta F
Methods Mol Biol; 2021; 2207():247-283. PubMed ID: 33113141
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin Based Nanosponges: A Multidimensional Drug Delivery System and its Biomedical Applications.
Mane PT; Wakure BS; Wakte PS
Curr Drug Deliv; 2021; 18(10):1467-1493. PubMed ID: 33902410
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-based nanosponges as promising carriers for active agents.
Allahyari S; Trotta F; Valizadeh H; Jelvehgari M; Zakeri-Milani P
Expert Opin Drug Deliv; 2019 May; 16(5):467-479. PubMed ID: 30845847
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin-based nanosponges: A critical review.
Sherje AP; Dravyakar BR; Kadam D; Jadhav M
Carbohydr Polym; 2017 Oct; 173():37-49. PubMed ID: 28732878
[TBL] [Abstract][Full Text] [Related]
15. Cyclodextrin Nanosponges: A Revolutionary Drug Delivery Strategy.
Singh S; Sharma K; Sharma H
Pharm Nanotechnol; 2023 Sep; ():. PubMed ID: 37807414
[TBL] [Abstract][Full Text] [Related]
16. Evolving Era of "Sponges": Nanosponges as a Versatile Nanocarrier for the Effective Skin Delivery of Drugs.
Mullick P; R Hegde A; Gopalan D; Pandey A; Nandakumar K; Jain S; Kuppusamy G; Mutalik S
Curr Pharm Des; 2022; 28(23):1885-1896. PubMed ID: 35585809
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
Mady FM; Ibrahim SR
Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
[TBL] [Abstract][Full Text] [Related]
18. Versatile Use of Nanosponge in the Pharmaceutical Arena: A Mini-Review.
Shrestha S; Bhattacharya S
Recent Pat Nanotechnol; 2020; 14(4):351-359. PubMed ID: 32875993
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
[TBL] [Abstract][Full Text] [Related]
20. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.
Salústio PJ; Pontes P; Conduto C; Sanches I; Carvalho C; Arrais J; Marques HM
AAPS PharmSciTech; 2011 Dec; 12(4):1276-92. PubMed ID: 21948320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
